Bruker cuts FY25 EPS view to $1.95-$2.05 from $2.40-$2.48, consensus $2.42

Cuts FY25 revenue view to $3.43B-$3.5B from $3.48B-$3.55B, consensus $3.52B. The company said, “Bruker (BRKR) today is announcing a significantly expanded cost management initiative, expected to reduce our annual costs by $100 – $120 million in FY 2026. This supports our commitment to resume rapid margin expansion and double-digit EPS growth next year, even in a scenario where demand remains muted. We are, however, optimistic for a FY 2026 partial demand recovery, and point to Bruker’s successful track record of rebounding very strongly from previous market disruptions.”